Both in Pharmaceuticals
Generate Biomedicines vs Zenas BioPharma
Over the past year GENB returned −11.5% and ZBIO returned −8.4%; their daily moves had a correlation of 0.41.
GENB −11.5% ZBIO −8.4%Growth of $1, one year, split-adjusted
| Metric | GENB | ZBIO |
|---|---|---|
| Price | $13.92 | $28.51 |
| Market cap | $1.79B | $1.86B |
| Today | +0.51% | +0.44% |
| 1 month | +0.9% | +5.8% |
| 6 months | — | +36.8% |
| Year to date | — | −21.5% |
| 1 year | — | −9.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1065.2% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,857.9× |
| Net cash | $452.3M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.9% |
| Short % of float | 15.4% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).